Richard M. Wright's most recent trade in Celldex Therapeutics Inc. was a trade of 65,000 Incentive Stock Option (right to buy) done . Disclosure was reported to the exchange on June 13, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celldex Therapeutics Inc. | Richard M. Wright | SR. VP & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 65,000 | 65,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Richard M. Wright | SR. VP & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 28,469 | 13,531 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Richard M. Wright | SR. VP & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.00 per share. | 03 Jun 2024 | 28,469 | 49,302 (0%) | 0% | 28 | 797,132 | Common Stock |
| Celldex Therapeutics Inc. | Richard M. Wright | SR. VP & CCO | Sale of securities on an exchange or to another person at price $ 33.53 per share. | 03 Jun 2024 | 27,580 | 40,097 (0%) | 0% | 33.5 | 924,658 | Common Stock |
| Celldex Therapeutics Inc. | Richard M. Wright | SR. VP & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.78 per share. | 03 Jun 2024 | 20,625 | 20,833 (0%) | 0% | 2.8 | 57,338 | Common Stock |
| Celldex Therapeutics Inc. | Richard M. Wright | SR. VP & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 20,625 | 0 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Richard M. Wright | SR. VP & CCO | Sale of securities on an exchange or to another person at price $ 33.99 per share. | 03 Jun 2024 | 19,264 | 20,833 (0%) | 0% | 34.0 | 654,695 | Common Stock |
| Celldex Therapeutics Inc. | Richard M. Wright | SR. VP & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2024 | 18,375 | 23,625 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Richard M. Wright | SR. VP & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.48 per share. | 03 Jun 2024 | 18,375 | 67,677 (0%) | 0% | 22.5 | 413,070 | Common Stock |
| Celldex Therapeutics Inc. | Richard M. Wright | SR. VP & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 45,000 | 45,000 | - | - | Incentive Stock Option (right to buy) | |
| WSFS Financial Corp. | Richard M. Wright | EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.95 per share. | 11 Jan 2023 | 6,852 | 32,678 (0%) | 0% | 45.9 | 314,849 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.38 per share. | 10 Dec 2022 | 686 | 39,530 (0%) | 0% | 46.4 | 31,817 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 880 | 40,216 (0%) | 0% | 0 | Common Stock | |
| WSFS Financial Corp. | Richard M. Wright | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2022 | 880 | 39,336 (0%) | 0% | 0 | Common Stock | |
| Celldex Therapeutics Inc. | Richard M. Wright | SR. VP & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.38 per share. | 15 Aug 2022 | 15,328 | 15,536 (0%) | 0% | 10.4 | 159,105 | Common Stock |
| Celldex Therapeutics Inc. | Richard M. Wright | SR. VP & CCO | Sale of securities on an exchange or to another person at price $ 37.71 per share. | 15 Aug 2022 | 15,328 | 208 (0%) | 0% | 37.7 | 578,048 | Common Stock |
| Celldex Therapeutics Inc. | Richard M. Wright | SR. VP & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 15,328 | 26,672 | - | - | Incentive Stock Option | |
| WSFS Financial Corp. | Richard M. Wright | EVP | Sale of securities on an exchange or to another person at price $ 49.66 per share. | 11 Aug 2022 | 3,740 | 38,456 (0%) | 0% | 49.7 | 185,724 | Common Stock |
| Celldex Therapeutics Inc. | Richard M. Wright | SR. VP & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 42,000 | 42,000 | - | - | Incentive Stock Option (right to buy) | |
| WSFS Financial Corp. | Richard M. Wright | EVP | Sale of securities on an exchange or to another person at price $ 42.03 per share. | 19 Apr 2022 | 1,973 | 42,196 (0%) | 0% | 42.0 | 82,925 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.78 per share. | 15 Apr 2022 | 1,967 | 44,169 (0%) | 0% | 41.8 | 82,181 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 5,912 | 46,136 (0%) | 0% | 0 | Common Stock | |
| WSFS Financial Corp. | Richard M. Wright | EVP | Sale of securities on an exchange or to another person at price $ 48.96 per share. | 14 Dec 2021 | 762 | 40,224 (0%) | 0% | 49.0 | 37,308 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.78 per share. | 10 Dec 2021 | 758 | 40,986 (0%) | 0% | 49.8 | 37,733 | WSFS Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Sale of securities on an exchange or to another person at price $ 53.66 per share. | 02 Nov 2021 | 1,733 | 41,744 (0%) | 0% | 53.7 | 92,996 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Sale of securities on an exchange or to another person at price $ 53.26 per share. | 25 Oct 2021 | 10,362 | 43,477 (0%) | 0% | 53.3 | 551,880 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.24 per share. | 25 Oct 2021 | 10,362 | 53,839 (0%) | 0% | 26.2 | 271,865 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2021 | 10,362 | 0 | - | - | Stock Options (Right to buy) | |
| WSFS Financial Corp. | Richard M. Wright | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.86 per share. | 25 Oct 2021 | 8,789 | 52,266 (0%) | 0% | 29.9 | 262,440 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Sale of securities on an exchange or to another person at price $ 53.58 per share. | 25 Oct 2021 | 8,789 | 43,477 (0%) | 0% | 53.6 | 470,915 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2021 | 8,789 | 0 | - | - | Stock Options (Right to buy) | |
| Celldex Therapeutics Inc. | Richard M. Wright | Sr. VP & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 42,000 | 42,000 | - | - | Incentive Stock Option (right to buy) | |
| WSFS Financial Corp. | Richard M. Wright | EVP | Sale of securities on an exchange or to another person at price $ 53.51 per share. | 02 Jun 2021 | 3,064 | 43,477 (0%) | 0% | 53.5 | 163,966 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Sale of securities on an exchange or to another person at price $ 52.45 per share. | 07 May 2021 | 4,072 | 46,541 (0%) | 0% | 52.4 | 213,560 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Sale of securities on an exchange or to another person at price $ 51.30 per share. | 30 Apr 2021 | 3,228 | 50,613 (0%) | 0% | 51.3 | 165,586 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Sale of securities on an exchange or to another person at price $ 50.56 per share. | 27 Apr 2021 | 1,234 | 53,841 (0%) | 0% | 50.6 | 62,391 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.92 per share. | 15 Apr 2021 | 1,294 | 55,075 (0%) | 0% | 49.9 | 64,596 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Sale of securities on an exchange or to another person at price $ 52.00 per share. | 12 Mar 2021 | 3,099 | 56,369 (0%) | 0% | 52 | 161,148 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 8,868 | 8,868 | - | - | Stock Options (Right to buy) | |
| WSFS Financial Corp. | Richard M. Wright | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 8,868 | 8,868 | - | - | Stock Options (Right to buy) | |
| WSFS Financial Corp. | Richard M. Wright | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 3,219 | 59,468 (0%) | 0% | 0 | Common Stock | |
| WSFS Financial Corp. | Richard M. Wright | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 3,219 | 59,468 (0%) | 0% | 0 | Common Stock | |
| WSFS Financial Corp. | Richard M. Wright | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 2,819 | 56,249 (0%) | 0% | 0 | Common Stock | |
| WSFS Financial Corp. | Richard M. Wright | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 2,819 | 56,249 (0%) | 0% | 0 | Common Stock | |
| Celldex Therapeutics Inc. | Richard M. Wright | Sr. VP & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.02 per share. | 14 Dec 2020 | 11,457 | 11,665 (0%) | 0% | 9.0 | 103,302 | Common Stock |
| Celldex Therapeutics Inc. | Richard M. Wright | Sr. VP & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2020 | 11,457 | 6,876 | - | - | Incentive Stock Option | |
| Celldex Therapeutics Inc. | Richard M. Wright | Sr. VP & CCO | Sale of securities on an exchange or to another person at price $ 18.61 per share. | 14 Dec 2020 | 11,457 | 208 (0%) | 0% | 18.6 | 213,175 | Common Stock |
| Celldex Therapeutics Inc. | Richard M. Wright | Sr. VP & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2020 | 9,375 | 20,625 | - | - | Incentive Stock Option | |
| Celldex Therapeutics Inc. | Richard M. Wright | Sr. VP & CCO | Sale of securities on an exchange or to another person at price $ 18.61 per share. | 14 Dec 2020 | 9,375 | 208 (0%) | 0% | 18.6 | 174,436 | Common Stock |
| Celldex Therapeutics Inc. | Richard M. Wright | Sr. VP & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.78 per share. | 14 Dec 2020 | 9,375 | 9,583 (0%) | 0% | 2.8 | 26,063 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 4,562 | 53,430 (0%) | 0% | 0 | Common Stock | |
| WSFS Financial Corp. | Richard M. Wright | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 14,025 | 0 | - | - | Stock Options (Right to buy) | |
| WSFS Financial Corp. | Richard M. Wright | EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.82 per share. | 02 Nov 2020 | 14,025 | 61,072 (0%) | 0% | 23.8 | 334,123 | Common Stock |
| WSFS Financial Corp. | Richard M. Wright | EVP | Sale of securities on an exchange or to another person at price $ 32.91 per share. | 02 Nov 2020 | 12,204 | 48,868 (0%) | 0% | 32.9 | 401,576 | Common Stock |